# Quality Score Report: Barrier 5 Cross-ADR Coherence Synthesis

## L0 Executive Summary

**Score:** 0.9035/1.00 | **Verdict:** REVISE | **Weakest Dimension:** Actionability (0.88)

**One-line assessment:** The synthesis is structurally sound and internally coherent — all four ADRs are covered, gate checks are satisfied, and no conflicts are missed — but it falls short of the 0.95 C4 threshold primarily because Methodological Rigor has an implicit-rather-than-explicit gate check mapping and an uncaveated AGREE-5 rank column, and Actionability lacks a consolidated action list that assigns owners and deadlines to the cross-cutting recommendations.

---

## Scoring Context

- **Deliverable:** `projects/PROJ-014-negative-prompting-research/orchestration/neg-prompting-20260227-001/barrier-5/synthesis.md`
- **Deliverable Type:** Cross-ADR coherence synthesis (Barrier 5)
- **Criticality Level:** C4
- **Quality Threshold:** 0.95 (project orchestration directive, overrides SSOT default of 0.92)
- **Scoring Strategy:** S-014 (LLM-as-Judge)
- **SSOT Reference:** `.context/rules/quality-enforcement.md`
- **Iteration:** I1
- **Scored:** 2026-02-28T00:00:00Z

---

## Score Summary

| Metric | Value |
|--------|-------|
| **Weighted Composite** | 0.9035 |
| **Threshold** | 0.95 (C4 project directive) |
| **Verdict** | REVISE |
| **Strategy Findings Incorporated** | No |

---

## Dimension Scores

| Dimension | Weight | Score | Weighted | Evidence Summary |
|-----------|--------|-------|----------|-----------------|
| Completeness | 0.20 | 0.92 | 0.1840 | All 8 synthesis tasks addressed, all 4 ADRs present in every analysis table; GC-B5-1 through GC-B5-5 satisfied; two coverage gaps honestly disclosed |
| Internal Consistency | 0.20 | 0.93 | 0.1860 | No contradictions found across 8 tasks; numbers consistent (28 SHOULD/MAY, 5 template recs) across Task 4, risk register, and Key Findings; Phase 2 gate classification in Task 2 matches Stage 6 gating in Task 6 |
| Methodological Rigor | 0.20 | 0.88 | 0.1760 | Formal dependency map, DAG check, 9-row PG-003 table, risk register, P-022 tensions table are rigorous; gate checks GC-B5-1 through GC-B5-5 are implicitly satisfied but never explicitly numbered/mapped in the document body; AGREE-5 rank column in Task 5 NPT table lacks a per-column caveat |
| Evidence Quality | 0.15 | 0.89 | 0.1335 | A-11 correctly excluded; AGREE-5 consistently labeled internally generated; T1/T3/T4 tier sourcing honest; 8 collective evidence gaps enumerated with resolution paths; GAP-X3 (53% YAML inference) and GAP-X8 (AGREE-5 unvalidated) disclosed |
| Actionability | 0.15 | 0.88 | 0.1320 | 6-stage ordering with file targets and acceptance gates; risk mitigations specific; 3-day time-box for token gate; but no consolidated action list with owner/deadline assignments — actions are scattered across risk register, tensions table, PS Integration, and Key Findings |
| Traceability | 0.10 | 0.92 | 0.0920 | Every finding cites contributing ADR and task; Source Summary maps all 7 inputs; implementation ordering rows carry ADR and dependency attribution; Stage 2 table cites specific recommendation IDs (REC-F-001 through REC-F-003) |
| **TOTAL** | **1.00** | | **0.9035** | |

**H-15 Arithmetic Verification:**
- 0.92 × 0.20 = 0.1840
- 0.93 × 0.20 = 0.1860
- 0.88 × 0.20 = 0.1760
- 0.89 × 0.15 = 0.1335
- 0.88 × 0.15 = 0.1320
- 0.92 × 0.10 = 0.0920
- Sum: 0.1840 + 0.1860 + 0.1760 + 0.1335 + 0.1320 + 0.0920 = **0.9035**

---

## Barrier-Specific Gate Check Results

| Gate Check | Status | Evidence |
|------------|--------|---------|
| GC-B5-1: All 4 ADRs analyzed in dependency, conflict, and coverage analysis | PASS | ADR-001 through ADR-004 appear in all 8 task tables (Task 1 dependency map, Task 2 Phase 2 classification, Task 3 PG-003, Task 4 coverage, Task 5 NPT taxonomy, Task 6 ordering, Task 7 conflict detection, Task 8 evidence roll-up) |
| GC-B5-2: Phase 2 dependency provisions coherent and non-contradictory | PASS | Task 2 provides 4-row classification table plus 4 numbered consistency verification points; unconditional/conditional split is internally consistent across all four ADRs; Tension 1 (ADR-001 unconditional vs. timing gate) correctly identified and resolved as a labeling issue, not a substantive contradiction |
| GC-B5-3: PG-003 contingency provisions consistent across all ADRs | PASS | Task 3 provides 9-row component-level table; three-part convergent pattern explicitly stated (structural additions retained, vocabulary reversible, mechanisms framing-independent); ADR-003 Component A "not reversible by design" correctly scoped to content vs. vocabulary |
| GC-B5-4: Implementation ordering respects all inter-ADR dependencies | PASS | Task 6 provides 6-stage ordering with acceptance gates; Tension 2 (ADR-003 Component A before ADR-001 Group 3 for routing disambiguation sections) is identified and given an explicit sequencing resolution; no circular dependencies in the DAG |
| GC-B5-5: Barrier-4 recommendation coverage gap analysis complete | PASS | Task 4 maps all barrier-4 categories to ADRs; three gaps identified (GAP 1: 28 TASK-013 SHOULD/MAY recs, GAP 2: 5 TASK-014 contrastive example recs, GAP 3: deferred eng-team/red-team refactor); coverage classification (FULL/PARTIAL/CONDITIONAL/DEFERRED/GAP) applied consistently |
| A-11 MUST NOT appear as citation | PASS | A-11 does not appear as a citation anywhere in the document; line 549 explicitly states "NEVER cite A-11 in any downstream implementation document. Confirmed hallucinated citation." |
| AGREE-5 MUST NOT be presented as T1 or T3 | PASS | AGREE-5 is labeled "internally generated, NOT externally validated" at lines 40, 383, 402, 516, 547, 551; explicitly classified as "Internal synthesis" in Task 8 evidence table; never presented as T1, T2, or T3 |

All seven gate checks pass. The score shortfall is not attributable to gate failures — it is attributable to rigor and actionability refinements that fall below the 0.95 C4 bar.

---

## Detailed Dimension Analysis

### Completeness (0.92/1.00)

**Evidence:**
The synthesis addresses all 8 synthesis tasks with dedicated sections. Task 1 (cross-ADR dependency analysis) includes a formal dependency map table, a "Which ADR first?" analysis, and a circular dependency check. Task 2 (Phase 2 coherence) includes a 4-row classification table and 4 numbered consistency points. Task 3 (PG-003) covers all 9 ADR components. Task 4 (barrier-4 coverage) maps all 17 barrier-4 categories. Task 5 (NPT taxonomy) covers all 14 NPT patterns. Task 6 (implementation ordering) spans 6 stages with acceptance gates. Task 7 (conflict detection) examines 5 potential conflicts. Task 8 (evidence roll-up) includes tier classification, missing tiers, 8 gaps, and evidence strength by decision.

The document structure is L0/L1/L2 as required. The Source Summary accounts for all 7 inputs. The Self-Review Checklist is complete. Coverage gaps are honestly disclosed rather than concealed.

**Gaps:**
The L2 section functions more as an L1 extension (roadmap + risk register + gap closure path) than as a strategic implications layer. It does not synthesize the aggregate risk profile into a strategic posture recommendation (e.g., "given this risk landscape, the overall implementation confidence is..."), which would add completeness at the strategic layer. This is a modest gap — the L2 content is present and useful, but it does not rise to a level of independent strategic insight.

**Improvement Path:**
Add a "Strategic Posture" paragraph to the L2 section that characterizes the aggregate implementation risk (e.g., conditional vs. unconditional ADR split ratio, Phase 2 as bottleneck, longest gap closure path). This would close the L2 strategic synthesis gap and push Completeness closer to 0.95.

---

### Internal Consistency (0.93/1.00)

**Evidence:**
The 28 TASK-013 SHOULD/MAY recommendation count (18 + 10) appears in Task 4 (lines 182-183), the risk register (CX-R-006: "28 recommendations"), and Key Findings (Finding 2: "28 SHOULD/MAY recommendations"). The numbers are consistent across all three locations.

The Phase 2 dependency classifications in Task 2 (ADR-001 UNCONDITIONAL, ADR-002 SPLIT, ADR-003 SPLIT, ADR-004 UNCONDITIONAL) are consistent with the Stage 6 gating in Task 6 — only ADR-002 Phase 5B and ADR-003 Component B appear in Stage 6 (conditional); unconditional components appear in Stages 1-4.

The evidence tier assignments in Task 8 (T1 for A-15/A-20, T3 for A-31, T4 for AGREE-5) are consistent with their usage in Task 5's NPT coverage table.

Tension 1 in Task 7 is the same tension identified in Task 2 Section "One Coherence Tension Identified" — the documents reference the same issue from complementary perspectives without contradiction.

**Gaps:**
No significant internal inconsistencies found. The only minor note: the dependency diagram (DAG) in Task 1 (lines 74-85) shows ADR-002 Phase 5A below ADR-001 in the hierarchy, but the relationship label in the dependency table is "ENABLES" from ADR-001 to ADR-002 — the visual and textual descriptions are technically consistent but the diagram conflates Phase 5A (immediate) with Phase 5B (conditional), which could briefly mislead a reader. This is not an internal contradiction but a minor clarity issue.

**Improvement Path:**
Add a "(Phase 5B only)" annotation to the ADR-002 box in the DAG diagram in Task 1. This would bring the diagram into precise alignment with the Phase 5A/5B split described in the text.

---

### Methodological Rigor (0.88/1.00)

**Evidence:**
The dependency analysis uses a formal 5-column table (From, To, Relationship, Nature) rather than narrative description. The circular dependency check explicitly constructs a DAG and asserts "No circular dependencies exist" with the graphical representation as evidence. The coverage analysis uses a 6-column table with granular coverage classifications. The PG-003 analysis uses a row-per-component structure that prevents aggregation errors (rather than saying "all ADRs are PG-003 reversible" as a blanket claim).

The risk register follows standard risk management format. P-022 tensions are formally numbered and enumerated. The implementation ordering uses acceptance gates between stages, creating a verifiable execution structure.

**Gaps:**
Two methodological gaps reduce the score from the 0.92 range to 0.88:

**Gap 1 — Gate check mapping is implicit, not explicit.** The scoring brief specifies GC-B5-1 through GC-B5-5 as barrier-specific checks. The synthesis satisfies each of these (as verified in the gate check table above), but the document body does not contain a "Gate Check" section or an explicit mapping from GC-B5-1 through GC-B5-5 to the sections that satisfy them. A reviewer must infer these mappings from the section structure. At C4 criticality, explicit gate check mapping is a methodological requirement, not an optional nicety.

**Gap 2 — AGREE-5 rank column in Task 5 NPT table lacks per-column caveat.** The Task 5 NPT coverage table includes an "AGREE-5 Rank" column. The table caption does not carry the "internally generated, NOT externally validated" warning that appears in the text prose. A reader scanning the table without reading the surrounding text could treat AGREE-5 ranks as objective external benchmarks. The warning appears in the introductory paragraph ("The Phase 3 taxonomy...identified 14 named patterns"), which partially mitigates this, but a column-level footnote or header annotation would meet the rigor standard for a C4 document.

**Improvement Path:**
1. Add a "Barrier Gate Check Summary" table at the start of L0 or at the end of L1 that explicitly maps GC-B5-1 through GC-B5-5 to the task sections that satisfy them, and asserts PASS/FAIL for each.
2. Add a footnote or column header annotation "(internally generated, see AGREE-5 caveat)" to the AGREE-5 Rank column in the Task 5 NPT table.

---

### Evidence Quality (0.89/1.00)

**Evidence:**
A-11 is correctly excluded — the document explicitly states "NEVER cite A-11" at line 549 and does not use it anywhere. AGREE-5 is consistently labeled "internally generated, NOT externally validated" at every point of reference (lines 40, 383, 402, 516, 547, 551). The three-stream T1+T3 evidence for ADR-001 (A-15 EMNLP 2024, A-20 AAAI 2026, A-31 arXiv 2312.16171) is correctly characterized as the strongest evidence basis.

The 8 collective evidence gaps are enumerated in Task 8 with resolution paths — this is evidence quality honesty rather than a deficiency. GAP-X3 (53% YAML content inferred) is a specific quantified disclosure. GAP-X8 (AGREE-5 external validation absent) is correctly noted as requiring a "future external validation study; not planned in current roadmap." Evidence tiers not represented in the ADR set (T2, T5) are explicitly disclosed.

The evidence strength by ADR decision table uses calibrated HIGH/MEDIUM/LOW-MEDIUM/LOW labels with stated justifications. ADR-003 Component B receives the lowest rating ("LOW — UNTESTED") which is the correct assessment.

**Gaps:**
The synthesis is a meta-analysis document, so its evidence quality score reflects primarily how faithfully it characterizes and propagates the evidence quality from the source ADRs. Within that scope, the characterization is honest and calibrated. The primary limitation is that the Task 5 NPT coverage table uses AGREE-5 ranks as column data without per-row caveats (see Methodological Rigor Gap 2), which creates a subtle evidence quality risk for readers who use the table without the surrounding text.

**Improvement Path:**
The evidence quality dimension would benefit from adding a brief "Evidence Ceiling Summary" paragraph in Task 8 that explicitly states the maximum claim the aggregate evidence supports — namely, that NPT-014 elimination is T1+T3 supported (unconditional) and everything else in the ADR set is conditional or provisional. This would make the evidence ceiling explicit at the aggregate level rather than requiring it to be inferred from the per-decision table.

---

### Actionability (0.88/1.00)

**Evidence:**
The 6-stage implementation ordering includes specific file targets (e.g., "`.context/rules/quality-enforcement.md`, `agent-development-standards.md`"), ADR attributions (e.g., "ADR-001 Group 1"), and acceptance gates (e.g., "Stage 0 complete", "token discrepancy resolved"). The risk register includes specific mitigations with ownership guidance. Tension 2 resolution includes a specific sequencing instruction ("ADR-003 Component A MUST be applied first to Group 2 skills... and ADR-001 Group 3 MUST treat the resulting table entries as the NPT-009 upgrade target"). The ADR-004 token gate is given a concrete 3-day time-box recommendation. A calendar duration estimate (9-20 weeks) with the critical path identified (Phase 2) is provided.

**Gaps:**
The synthesis's actionable findings are scattered across five separate sections: Task 6 (implementation ordering), Task 7 tensions (sequencing resolutions), Task 4 gaps (TASK-017 recommendation), the risk register (mitigations), and PS Integration Key Findings. There is no consolidated action list that brings together all discrete actions with owner type, suggested deadline, and blocking dependencies in one place. A practitioner who needs to begin Stage 0 must read the entire document to collect all the action constraints.

Specifically missing: a table or numbered list of the form "Cross-ADR Actions Required Before Stage 1 Begins" that consolidates (1) resolve 559/670 token discrepancy, (2) capture Phase 2 baseline, (3) create TASK-017, (4) apply ADR-001 clarifying note, (5) obtain user P-020 approval for all four ADRs. These are scattered across multiple sections but never gathered in one executable list.

**Improvement Path:**
Add a "Cross-ADR Action Register" table as the first subsection of L2, listing all actions that the synthesis has identified as necessary (not already assigned to a specific ADR implementation step), with columns: Action ID, Action, Owner Type, Timing Constraint, Source Section. This would consolidate the scattered actionable findings and make the synthesis directly executable for the project team.

---

### Traceability (0.92/1.00)

**Evidence:**
Every synthesis finding in Tasks 1-8 cites the contributing ADR by ID and, in most cases, by component (e.g., "ADR-002 Phase 5A", "ADR-003 Component A"). The Source Summary table maps all 7 input documents to specific task contributions. The implementation ordering rows carry both "ADR" and "Dependencies" columns. Stage 2 table cites specific recommendation IDs (REC-F-001 through REC-F-003, REC-YAML-001, REC-YAML-002), which is strong sub-ADR traceability. The risk register carries an "ADR Source" column. The evidence gap table carries an "Affected ADRs" column. The NPT taxonomy table carries an "Addressed by ADR" column.

**Gaps:**
The traceability is strong throughout. The minor limitation is that most implementation ordering rows cite the ADR name and group (e.g., "ADR-001 Group 1") but not the specific section or decision ID within the ADR (e.g., "ADR-001 Section 4.1 Decision D-001"). This would allow a reviewer to navigate directly from the implementation ordering table to the precise ADR section authorizing each change. Stage 2 is an exception (cites REC-F-001 etc.) — the other stages would benefit from similar precision.

**Improvement Path:**
Add a "Decision Ref" column to the Stage 1, 3, 4, and 6 implementation tables that cites the specific ADR section or decision identifier (R-QE-001, D-007, Sub-4, etc.) authorizing each action. This would bring those tables to the same traceability precision as Stage 2.

---

## Improvement Recommendations (Priority Ordered)

| Priority | Dimension | Current | Target | Recommendation |
|----------|-----------|---------|--------|----------------|
| 1 | Methodological Rigor | 0.88 | 0.93 | Add a "Barrier Gate Check Summary" table (GC-B5-1 through GC-B5-5, explicit PASS/FAIL with section citations) at the end of the L0 section or as a preamble to L1. This is the highest-leverage fix because it directly addresses an explicit C4 gate requirement. |
| 2 | Actionability | 0.88 | 0.93 | Add a "Cross-ADR Action Register" table as the first subsection of L2, consolidating all cross-cutting actions identified in the synthesis (token gate resolution, baseline capture, TASK-017 creation, ADR-001 labeling clarification note, P-020 approval) with owner type, timing constraint, and source section. |
| 3 | Methodological Rigor | — | — | Add a per-column footnote or header annotation "(internally generated — see AGREE-5 caveat)" to the AGREE-5 Rank column in the Task 5 NPT coverage table. |
| 4 | Actionability | — | — | Add a "Decision Ref" column to the Stage 1, 3, 4, and 6 implementation tables (matching the precision already present in Stage 2's REC-F-001 through REC-F-003 citations). |
| 5 | Completeness | 0.92 | 0.95 | Add a "Strategic Posture" paragraph to L2 that characterizes the aggregate implementation risk (unconditional/conditional ratio, Phase 2 as bottleneck, Stage 2 coordination as the highest operational risk, longest gap closure path). |
| 6 | Evidence Quality | 0.89 | 0.92 | Add a brief "Evidence Ceiling Summary" paragraph to Task 8 that explicitly states the maximum supportable aggregate claim (NPT-014 elimination T1+T3 unconditional; everything else conditional or provisional), closing the gap between per-decision evidence strength and aggregate evidence characterization. |
| 7 | Internal Consistency | 0.93 | 0.95 | Add "(Phase 5B only)" annotation to the ADR-002 box in the Task 1 DAG diagram to precisely reflect the Phase 5A/5B split and prevent diagram-vs-text ambiguity. |
| 8 | Traceability | 0.92 | 0.95 | Add a "Decision Ref" column to Stage 1, 3, 4, and 6 implementation tables with specific ADR section/decision identifiers (matching Stage 2 precision). |

**Expected score after Priority 1-4 fixes:** Approximately 0.930-0.935.

**Expected score after all 8 fixes:** Approximately 0.950-0.955, which would clear the C4 0.95 threshold.

---

## Leniency Bias Check

- [x] Each dimension scored independently before computing the weighted composite
- [x] Evidence documented for each score — specific lines, tables, and sections cited
- [x] Uncertain scores resolved downward: Methodological Rigor held at 0.88 (not 0.90) due to the gate check mapping gap; Actionability held at 0.88 (not 0.90) due to the consolidated action list gap
- [x] First-draft calibration considered: this is I1, so 0.88-0.93 across dimensions is consistent with a strong first draft that has not yet undergone targeted revision
- [x] No dimension scored above 0.95 — the highest score is 0.93 (Internal Consistency), which is warranted by the absence of any contradictions found across the full document
- [x] Gate-check-specific verification performed: all 7 barrier-specific checks evaluated; score shortfall is not attributable to gate failures

---

## Session Context Handoff

```yaml
verdict: REVISE
composite_score: 0.9035
threshold: 0.95
weakest_dimension: actionability
weakest_score: 0.88
critical_findings_count: 0
iteration: 1
improvement_recommendations:
  - "Add Barrier Gate Check Summary table (GC-B5-1 through GC-B5-5 with explicit PASS/FAIL and section citations) — highest-leverage fix"
  - "Add Cross-ADR Action Register table to L2 consolidating all cross-cutting actions with owner type, timing constraint, and source section"
  - "Add AGREE-5 per-column caveat annotation to Task 5 NPT coverage table AGREE-5 Rank column"
  - "Add Decision Ref column to Stage 1, 3, 4, 6 implementation tables matching Stage 2 REC-F precision"
  - "Add Strategic Posture paragraph to L2 characterizing aggregate implementation risk"
  - "Add Evidence Ceiling Summary paragraph to Task 8 stating maximum supportable aggregate claim"
  - "Annotate ADR-002 box in Task 1 DAG with (Phase 5B only) to prevent diagram-vs-text ambiguity"
  - "Apply Decision Ref column traceability improvement across remaining stage tables"
```

---

*Scored by: adv-scorer*
*Iteration: I1*
*Scoring Strategy: S-014 LLM-as-Judge*
*Threshold Applied: 0.95 (C4 project orchestration directive)*
*SSOT: `.context/rules/quality-enforcement.md`*
*Date: 2026-02-28*
